Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes retail...

    NPPA fixes retail prices of 14 formulations

    Written by Ruby Khatun Khatun Published On 2018-01-02T15:45:13+05:30  |  Updated On 2 Jan 2018 3:45 PM IST
    NPPA fixes retail prices of 14 formulations

    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has fixed Retail prices of 14 formulations under DPCO 2013 exclusive of goods and services tax (GST).


    The notice states that in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), hereby fixes the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry with the strength, unit and name of manufacturer & marketing company.


    Following are the details































































































































    Sl. NoName of the Scheduled Formulation/Brand NameStrengthUnitManufacturer & Marketing
    Company
    Retail
    Price (Rs.)
    1.Cilnidipine + Metoprolol TabletEach film coated Bi-Layered tablet contains: Cilnidipine 10mg, Metoprolol Succinate IP 47.5mg eq. to Metoprolol Tartrate 50mg (ER)1 TabletM/s Pure and Cure Healthcare Pvt Ltd./M/s Intas Pharmaceuticals Pvt. Ltd.7.346
    2.Metformin +
    Glimepiride + Voglibose Tablets
    Each tablet contains:
    Metformin HCL 500mg (as sustained release form) Glimepiride 1mg
    Voglibose 0.3mg
    1 TabletM/s Sunglow
    Pharmaceuticals Pvt. Ltd./M/s Intas Pharmaceuticals Ltd.
    8.17
    3.Rosuvastatin + Clopidogrel CapsuleEach Hard gelatin capsule contains:
    Rosuvastatin Calcium IP eq. to
    Rosuvastatin 20mg,
    Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg
    1 CapsuleM/s Synokem
    Pharmaceuticals Ltd./M/s Cadila Pharmaceuticals Ltd.
    7.80
    4.Telmisartan +
    Chlorthalidone Tablet (Tigatel CH80)
    Each film coated tablet contains:
    Telmisartan IP 80mg, Chlorthalidone IP 12.5mg
    1 TabletM/s Sun Pharma
    Laboratories
    Limited
    6.713
    5.Rosuvastatin + Clopidogrel CapsuleEach hard gelatin capsule contains:
    Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As pellets) Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (As pellets)
    1
    Capsule
    M/s Synokem
    Pharmaceuticals Ltd. / M/s Zydus Healthcare Ltd.
    7.80
    6.Paracetamol+Caffeine+ Phenylephrine+
    Diphenhydramine
    Tablet (Sinus77)
    Each uncoated tablet contains: Paracetamol-500mg
    Caffeine (anhydrous)-30mg
    Phenylephrine HCl-5mg Diphenhydramine HCl-25mg
    1 TabletM/s Dales Laboratories Pvt. Ltd.2.57
    7.Atorvastatin +
    Clopidogrel Capsule
    Each hard gelatin capsule contains:
    Atorvastatin Calcium IP eq. to Atorvastatin 10mg, Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg
    1
    Capsule
    M/s Synokem
    Pharmaceuticals Ltd. / M/s Eris
    Lifesciences Limited
    8.394
    8.Atorvastatin +
    Clopidogrel Capsule
    Each hard gelatin capsule contains:
    Atorvastatin Calcium IP eq. to Atorvastatin 20mg, Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg
    1
    Capsule
    M/s Synokem
    Pharmaceuticals Ltd. / M/s Eris
    Lifesciences Limited
    10.596
    9.Gliclazide + Metformin Tablet (Glychek M +)Each uncoated tablet contains: Gliclazide IP 40mg, Metformin Hydrochloride IP 500mg1 TabletM/s Akums Drugs &
    Pharmaceuticals Ltd. / M/s Indoco Remedies Limited
    4.354
    10.Atorvastatin + Clopidogrel Capsule (Atocor CV 20mg)Each hard gelatin capsule contains:
    Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As two film
    coated tablet Each containing Atorvastatin 10mg)
    Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (As 2 film coated 37.5mg each tablet)
    1
    Capsule
    M/s Windlas
    Biotech Pvt. Ltd. / M/s Dr. Reddy’s Laboratories Ltd.
    10.596
    11.Atorvastatin +
    Clopidogrel Capsule (Avas 20 Gold)
    Each capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As film-coated tablet) Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (As 2 film coated 37.5mg each tablet)
    1
    Capsule
    M/s Micro Lab. Ltd.10.596
    12.Atorvastatin +
    Clopidogrel Capsule (Astin 20 Gold)
    Each capsule contains:
    Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As film-coated tablet) Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (As 2 film coated 37.5mg each tablet)
    1
    Capsule
    M/s Micro Lab. Ltd.10.596
    13.Rosuvastatin +
    Clopidogrel Capsule
    Each hard gelatin capsule contains:
    Rosuvastatin Calcium IP eq. to
    Rosuvastatin 10mg,
    Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg
    1
    Capsule
    M/s Synokem
    Pharmaceuticals Ltd. / M/s Eris
    Lifesciences Limited
    13.37
    14.Rosuvastatin +
    Clopidogrel Capsule
    Each hard gelatin capsule contains:
    Rosuvastatin Calcium IP eq. to
    Rosuvastatin 20mg, Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg
    1
    Capsule
    M/s Synokem
    Pharmaceuticals Ltd. / M/s Eris
    Lifesciences Limited
    7.80


    Below is the attachment for the same.


    http://www.nppaindia.nic.in/order/formulation_prices(14).pdf


    Medical Dialogues had earlier reported that NPPA had notified prices of 27 essential formulations, including those used for the treatment of diabetes, blood pressure and pain.


    Read also: NPPA fixes prices of 27 essential formulations

    14 formulationsDepartment of PharmaceuticalsDPCODrugs Prices Control OrderfixesGoods and Services TaxGovernment of IndiaGSTMinistry of Chemicals and FertilizersNational Pharmaceutical Pricing AuthorityNPPARetail Prices

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok